Feb. 25, 2019 – Even as the Centers for Medicare & Medicaid Services considers comments received on a federal proposal to mandate the inclusion of the wholesale acquisition cost (WAC) of prescription drugs in consumer television ads, the state of Oregon is weighing whether or not to require a disclosure regarding the wholesale cost that […]
Read more
April 2, 2018 – An Oregon transparency bill introduced in February was signed into law March 13 by Oregon Gov. Kate Brown (D), requiring drug companies not only to report drug prices to the state annually, but also to report costs associated with developing and marketing their drugs. “The Oregon bill (HB 4005) is the […]
Read more Feb. 5, 2018 – A bill to increase price transparency in Oregon, scheduled to be introduced Feb. 5, would require prescription drug manufacturers not only to report drug prices to the state annually, but also would require them to report costs associated with developing and marketing their drugs. If passed, Oregon House Bill 4005 would […]
Read moreMarch 9, 2017 – Four major advertising and media industry groups have issued a joint letter opposing an Oregon bill (S.B. 792) that would require manufacturers to disclose prescription drug wholesale prices in any ads run in the state or face potential civil penalties of up to $5,000 per ad publication or broadcast. According to […]
Read more